Kromek Group plc (AIM:KMK)
London · Delayed Price · Currency is GBP · Price in GBX 6.50
0.00 (0.00%)
Sep 25, 2026, 4:35 PM GMT
Kromek Group Financials Overview
Financials in millions GBP. Fiscal year is May - April.
Millions GBP. Fiscal year is May - Apr.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Revenue Revenue Growth | 27.12 | 27.12 | 26.51 | 19.4 | 17.31 | 12.06 |
Revenue Growth | -28.35% | 2.30% | 36.61% | 12.10% | 43.58% | 16.45% |
Gross Profit Gross Profit Growth | 17.04 | 17.04 | 21.43 | 10.71 | 8.94 | 5.64 |
Operating Income Operating Income Growth | 2.91 | 2.91 | 4.74 | -1.89 | -6.13 | -7.11 |
Net Income Net Income Growth | 0.73 | 0.73 | 3.75 | -3.29 | -6.1 | -4.92 |
Earnings Per Share EPS Growth | 0.00 | 0.00 | 0.01 | -0.01 | -0.01 | -0.01 |
EPS Growth | -94.83% | -82.91% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 |
Advanced Imaging Advanced Imaging Growth | 19.85 | 19.85 | 27.83 | 17.59 |
Cbrn/biological-threat Detection Cbrn/biological-threat Detection Growth | 7.26 | 7.26 | 7.66 | 13.23 |
Inter-segment Sales Inter-segment Sales Growth | - | - | -8.99 | -11.42 |
Total Total Growth | 27.12 | 27.12 | 26.51 | 19.4 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Cash & Investments Cash & Investments Growth | 4.16 | 4.16 | 1.7 | 0.47 | 1.1 | 5.08 |
Total Debt Total Debt Growth | 9.36 | 9.36 | 4.05 | 12.29 | 13.38 | 11 |
Net Cash (Debt) Net Cash Growth | -5.19 | -5.19 | -2.35 | -11.82 | -12.28 | -5.92 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.01 | -0.01 | -0.00 | -0.02 | -0.03 | -0.01 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 3.06 | 3.06 | 15.9 | -2.8 | 0.2 | -3.53 |
Capital Expenditures CapEx Growth | -0.34 | -0.34 | -0.19 | -0.15 | -0.27 | -0.65 |
Free Cash Flow Free Cash Flow Growth | 2.72 | 2.72 | 15.72 | -2.95 | -0.07 | -4.18 |
Free Cash Flow Growth | -84.10% | -82.69% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Gross Margin | 62.82% | 62.82% | 80.85% | 55.20% | 51.62% | 46.75% |
Operating Margin | 10.72% | 10.72% | 17.87% | -9.75% | -35.39% | -58.95% |
Pretax Margin | 9.37% | 9.37% | 11.62% | -17.81% | -42.13% | -50.84% |
Profit Margin | 2.70% | 2.70% | 14.16% | -16.97% | -35.24% | -40.80% |
FCF Margin | 10.04% | 10.04% | 59.29% | -15.19% | -0.42% | -34.68% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 26, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
PE Ratio | 65.00 | 93.85 | 8.71 | - | - | - |
Forward PE | 28.26 | 36.21 | 9.11 | 28.81 | 28.81 | 28.81 |
P/FCF Ratio | 15.65 | 25.28 | 2.08 | - | - | - |
PS Ratio | 1.57 | 2.54 | 1.23 | 2.17 | 1.65 | 3.67 |